Drawing for ZYALA

USPTO serial 79104011

ZYALA

Reviewed by CopyMark Law Group

Reg. 4231920Status 404
Filing date
Status date
Registration date
Oct 30, 2012
Examiner
SHARMA, NAPOLEON
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ZYALA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of cancer, sepsis, tumors, skin ulcers and bacterial infection and to modulate the immune systemSECTION 71 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 2, 2022DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Apr 2, 2022DETHDEATH OF INTERNATIONAL REGISTRATION
Mar 20, 2020INNTTOTAL INVALIDATION PROCESSED BY THE IB
Feb 26, 2020INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Feb 25, 2020INPCINVALIDATION PROCESSED
Jan 31, 2020INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Sep 19, 2019ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB
May 31, 2019C71TCANCELLED SECTION 71
Feb 10, 2014CHLDCHANGE OF OWNER RECEIVED FROM IB
Jul 14, 2013FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Jun 26, 2013FICSFINAL DISPOSITION NOTICE SENT TO IB
Jun 26, 2013FIMPFINAL DISPOSITION PROCESSED
Jan 30, 2013FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 30, 2012R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 15, 2012GPNXNOTIFICATION PROCESSED BY IB
Aug 14, 2012PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 25, 2012OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 25, 2012OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 25, 2012NPUBNOTICE OF PUBLICATION
Jul 7, 2012PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 6, 2012CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jul 6, 2012ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN
Jul 6, 2012CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jul 5, 2012TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Jul 5, 2012CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 5, 2012ALIEASSIGNED TO LIE
Jun 21, 2012TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 27, 2012RFNTREFUSAL PROCESSED BY IB
Jan 6, 2012RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 6, 2012RFRRREFUSAL PROCESSED BY MPU
Jan 6, 2012RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 5, 2012CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 3, 2012DOCKASSIGNED TO EXAMINER
Nov 15, 2011MAFRAPPLICATION FILING RECEIPT MAILED
Nov 9, 2011NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 3, 2011REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance